Novocell creates, delivers and commercializes cell and drug therapies. As the medical community enters the century of the cell , the advent of stem cell engineering offers the potential to produce true disease-modifying treatments and cures for many debilitating, degenerative disorders, such as diabetes and cancer. Novocell s goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. To achieve this goal, the company is positioned to exploit human stem cell engineered product opportunities using its proprietary cell encapsulation technology. These technologies will allow large numbers of patients to be implanted with disease curing cells without the use of immunosuppression. Novocell s technology platform has an application to a range of diseases and conditions where the only effective treatment will be the replacement of nonfunctional cells. These include Parkinson s disease, spinal cord injury, stroke, thyroid malfunction and chronic liver failure. Novocell is headquartered in Irvine, Calif.